My Pregnancy Journal
Heartbeat- Can it predict the Sex of the baby?
By: Cheryl Weedmark
This week we heard our baby’s heartbeat for the first time! WOW!!!! I mean, seeing the baby in our first ultrasound appointment was cool- but hearing the heartbeat just made me melt and fall in love with this tiny little thing. It actually kicked our midwife as she was trying to hear it with the Doppler. He/she is feisty already (takes after their Mommy)!!! So, of course everyone wanted to know the heartbeat. Was it high….low- does that mean girl or boy? I don’t know. On Monday, at our appointment, the baby’s heartbeat was between 150-155.
Apparently this belief is based on the fact that women usually have higher metabolic rates than men and, therefore, have a slightly higher pulse rate. From what I have been able to find online there is no correlation between fetal heart rate and gender. It’s one of those old wives tales.
Anyone heard anything different??? I’ll tell you what. Send me your predictions to cheryl@cherylweedmark.com I’m going to start a pole. We ARE going to find out the gender in early March- so I will be sure and post the results and winners names. Maybe I’ll even give something away to the winners!!!
Happy guessing.
WEEK 15
You may not know it when it happens, but your tiny tenant frequently gets the hiccups, which babies master before breathing. Babies don’t make any sound because their trachea is filled with fluid rather than air.
Although you’ve probably gained between 5 and 10 pounds / 2.2 – 4.5 kilograms, the fetus weighs in at around only 2.5 ounces / 70 grams. It measures nearly 4 inches / 11 centimeters long, crown to rump. Legs are growing longer than the arms now, fingernails are fully formed and all the joints and limbs can move. You may be able to find out the sex of your baby by ultrasound now, since the external genitals may be developed enough that the ultrasound technician can tell you if you’re going to have a boy or a girl.
If the idea of having a baby seems so remote, nothing makes it feel more real than feeling your baby move for the first time. Most moms-to-be discern movement (called quickening) between 16 and 20 weeks. If you’ve been pregnant before, you’ll feel things earlier rather than later. What you may first think is a rumbling stomach may be your baby doing some back flips. Make note of when you first start feeling the baby and tell your midwife or doctor at your next visit. This middle stage of pregnancy is a good time to start exercising.
A Reproductive Endocrinologist Looks at Bioidentical Hormone Replacement Therapy
Southern Ontario Fertility Technologies
555 Southdale Rd, Suite 107
London, ON, N6E 1A2
Phone: (519) 685-5559
Fax: (519) 685-5519
E-mail: info@soft-infertility.com
www.soft-infertiity.com
Introduction
Bioidentical hormone replacement therapy (BHRT) refers to the use of exactly the same hormones that are made in a woman’s body premenopausally to replace her hormones in the menopause or supplement her hormones in the perimenopause.
Although this form of hormone replacement therapy has been carried on for many years, it has not been mainstream medicine. Mainstream medicine has made use of pharmaceutical products for hormone replacement therapy (HRT). Sometimes the products used are not exactly the same structure as a woman’s own hormones and in fact they can be chemical structures which do not exist normally in nature.
In a land to pay a site or send a fun and a massive wall and when he BHRT has gained tremendous popularity after the completion of the Woman’s Health Initiative (WHI) in 2004. That study answered a very specific question about pharmaceutical HRT but unfortunately was widely publicized and poorly understood. Many women, who would still benefit from conventional HRT, were and are denied it from the medical profession. This unfulfilled need for relief of menopausal symptoms, along with some very high profile promoters and generally good publicity about BHRT have skyrocketed its use.
How does a Reproductive Endocrinologist get Involved?
Reproductive endocrinology and infertility is a subspecialty of obstetrics and gynecology. As such, we are the most knowledgeable and up-to-date physicians on Women’s Hormone issues. In my training, I have been involved in research using conventional pharmaceutical hormone replacement products. I have prescribed conventional HRT for many years. I, like most physicians, in the past dismissed BHRT as an unnecessary form of alternate medical care.
In 2003, a good friend and compounding pharmacist who compounded products for our in fertility treatments approached me about prescribing BHRT. At first I was quite reluctant but agreed to do some personal research. Unfortunately, very little was available in the usual medical literature. Its proponents and promoters supply most information about BHT. Many of them were advertising their services on the Internet. Other information could be found in books available to the general public but not specifically written for physicians.
However, after doing some research, I felt that this seemed to be a not unreasonable approach to relieving menopausal symptoms. Most of the women presenting at my clinic for this treatment were already fairly knowledgeable about it and highly motivated. After giving detailed informed consent, I started to prescribe BHRT. I realized after a few patients that BHT was effective and had very few side effects. Generally, the response to treatment was better than I expected from my previous use of pharmaceutical products.
Since 2003, I have continued to prescribe BHRT and become much more knowledgeable about it and continue to be pleasantly surprised with the results. I have done some clinical research on my patient’s responses and being able to present this recently at an annual scientific meeting.
The principles of BHRT
| 1) Structurally same as premenopausal hormones
2) Pharmaceutical grade
3) Consider all three groups of hormones
4) Measure and adjust the response of the hormones to optimize treatment
5) Deliver the hormones in individually prepared creams or other delivery vehicles
6) Compounded |
As stated in the introduction, the first principle of BHRT is that the hormones prescribed have exactly the same structure as the hormones produced by the body premenopausally. However, that is not the only principle of BHT and the fact that there are more principles is often overlooked by medical practitioners and is why they sometimes disappoint patients who are interested in receiving BHRT.
The second principle of BHT is that the hormones used are of pharmaceutical grade. This means that they must be prescribed by a licensed physician. BHRT is often confused with over-the-counter preparations for menopausal symptoms which will contain some estrogen progesterone or testosterone. Although these natural products are probably of some benefit, they do not match the potency of the pharmaceutical grade hormones that are used in BHRT.
Another principle of BHRT is that all three major groups of hormones are considered. This is in contrast to the traditional medical approach to HRT. Most physicians have been taught that once a hysterectomy is done that progesterone replacement is no longer required. Seldom with conventional HRT is testosterone considered.
Another principle is that in general BHRT is often delivered in cream. BHRT can also be delivered via compounded capsules, lozenges, sublingual tablets or other methods but creams are most common. Also, BHRT is usually compounded by a compounding pharmacist.
Yet another principle of BHRT is that hormone levels are adjusted to each individual patient. True practitioners and advocates of BHRT suggest that salivary hormone testing is more accurate than blood hormone testing. Although hormone testing using saliva is not a true principle of BHT, certainly following the patients’ response and perhaps using blood or saliva testing to individualize the dose is important.
Reaction of the Medical Community
The medical community has been very reluctant to accept BHRT. Most physicians think of it as alternate medical care in much the way they would think of Chinese medicine, acupuncture, or naturopaths. Part of this reaction is because it is not taught formally in medical school or through continuing medical education. In fact, many senior residents that I teach have not been taught even about conventional HRT. We seem to have abandoned women. In addition to this, much of our medical training is supported and promoted by the pharmaceutical industry. In general, the pharmaceutical industry has been very resistant to BHRT. Even though the raw hormones used to compound the creams used in BHRT are sold and produced by the pharmaceutical industry, there has been a great deal of resistance. In fact, Wyeth pharmaceutical company made a petition to the FDA in the United States to stop compounding pharmacist from distributing BHRT.
Because of the intense interest in BHRT, most of the major medical organizations directly affected by BHRT have made some policy statement about it. In fact, the American Society of Reproductive Medicine offered a workshop a few years ago at one of their annual meetings. In general, they recognize the consumer pressure for prescribing BHRT and concede physicians can meet the demand by prescribing pharmaceutical products, which contain bioidentical hormones. However, what they overlook is the fact that there are several other principles of bioidentical prescribing (as listed above). In my experience it has been usually this “whole package” that informed women seeking BHRT are looking for.
One of the justified criticisms of BHRT is its lack of quality control. The prescribing physician is totally at the mercy of the pharmacist who prepares his prescription. Pharmaceutical companies are required to perform quality control on their products and therefore the physician can be very confident that when he prescribes a pill that it does exactly what he is used to having it do.
Enter the Compounding Pharmacist
As stated in the last section, a physician can write a prescription for BRHT and is totally dependent on the pharmacist who compounds it to supply the patient with a consistent product. Some pharmacists have little interest in compounding pharmaceutical products and some pharmacists have undergone additional training to add compounding to their pharmacy. Pharmacists, like other professionals have organizations that oversee them. Compounding pharmacists can enroll in organizations, which not only test and supply their products but also will offer them continuing medical education.
Most physicians who prescribe BHRT on a regular basis, like myself, insist that their patients take the prescription to a compounding pharmacist known to them. My usual compounding pharmacist is a member of Professional Compounding Centers of America (PCCA). The cream base he uses he purchases from them and it promotes hormone absorption and can be used vaginally as well as on the skin. I have had several experiences where a patient has taken their prescription to an alternate pharmacist and returned later to say that it no longer works. In delving into this I have consistently found that even though the prescription has been filled accurately it has not been compounded in the same way.
The controversy within BHRT
Proponents of BHRT are not a unified group. Some BHRT prescribing physicians will insist that estrogen needs only to be estradiol. Estradiol only makes up about 20% of the estrogen normally in a woman’s body. Those physicians will argue that once estradiol enters the body, that the body proportionate it into the other forms. Other physicians will argue that estrogen should be prescribed as two estrogens: estradiol and estriol in approximately the proportion that they are present in the normal female premenopausal body. Still other physicians promote the prescription of a triple estrogen consisting of estradiol, estriol and estrone. My own personal view of this is that Biest which is a mixture of 20% estradiol and 80% estriol is a very good product. Although the medical evidence for this mixture of estrogen is not strong, my own clinical experience is that it works very well and the estriol component is extremely useful for use on mucous membranes such as the lining of the vagina and the area just outside the vagina. Never in my medical career have I seen atrophic vaginitis respond faster than when I have the patient applies cream containing estriol to the affected areas.
Another controversy among proponents of BHRT is cycling versus no cycling. Proponents of cycling hormones will argue that women naturally cycle premenopausally. Also, they will argue that a brief break especially from progesterone will rejuvenate hormone receptors. Others argue that continuous treatment with the same level of hormones is beneficial and does not cause relapses in the unpleasant side effects of menopause. My own personal view of this is based on my previous experience with pharmaceutical products. Often, when a woman is premenopausal or just newly menopausal I will ask them to cycle the BHRT. However, once menopause has been established for at least one year, cycling is no longer necessary and just makes the treatment regime more complicated.
Another extremely important controversy among proponents of BHRT is about the goal of hormone replacement. One extreme are proponents of hormone restoration therapy. These practitioners believe that menopause is an abnormal condition and that hormone levels, usually based on saliva testing, should be brought into the usual premenopausal range and kept there. On the other extreme are practitioners who believed the goal of BHRT should be to improve quality of life and relieve any abnormal symptoms attributed to the menopause. These practitioners may not measure hormone levels and if they do usually believe that relief of symptoms and promotion of general well-being are more important than hormone blood levels. My personal belief is that menopause is an abnormal situation. In 1900, the average life expectancy for a woman was 45 years old and the average age of menopause was also 45 years old. Therefore, most women did not live long into menopause. It is only our recent improvements in medical care, nutrition, and housing that led to the abnormal situation of us living a great deal longer. It is unlikely that we as a species have been able to adapt to the loss of our hormones for up to 50 years of our life. However, I have not found testing hormone levels either through saliva or blood very useful in determining the exact dosage of hormones. Salivary hormone testing can be more expensive than a hormone replacement itself. My experience has been similar to my experience my experience in conventional hormone replacement therapy. I use blood testing to determine that the body is absorbing the hormones properly and I use the patient’s symptoms to adjust the dosage to maximize the clinical response. I am not sure that there is a “correct” level. Premenopausal women vary greatly from each other with respect to their hormone levels and even the same woman has very different hormone levels at different times of her cycle so I am not sure how we can determine that “correct” level.
Some promoters of BHRT also become experts on other hormones. They will test adrenal hormones, thyroid hormones, melatonin as well as many other hormones. My specialty training involves mostly reproductive hormones but we get involved a little bit with the thyroid gland because abnormalities in thyroid function can impinge on infertility. Therefore, in my practice of BHT, I concentrate almost solely on estrogen, progesterone, and testosterone.
Is BHRT Safer than HRT?
Many women who present for BHRT do so because they believe it is safer than HRT. This is promoted in much of the literature on BHRT presented in the Internet or in books. This may or may not be true. There is some limited information that estriol may be a safer estrogen than estradiol. However, this is based on mostly animal studies and studies which are very limited in number studied. There is also some evidence that natural progesterone may be safer than the very commonly used progestins that were used in many of the pharmaceutical products.
However, I counsel my patients that we do not know that BHRT is safer than conventional HRT. Also, we may never results this question. Because BHT is individualized to the patient is very unlikely that any medical scientist can perform a study containing enough patients to demonstrate BHRTs safety. The WHI contained many thousand of patients and cost millions of dollars to administer. Any side effects that were demonstrated occurred rarely and therefore required huge number of patients to demonstrate their significance. In addition, studies like the WHI were funded by the pharmaceutical industry. Such funding for BHRT is unlikely to happen.
However, all is not lost. It is my clinical opinion that the dangers of even conventional hormone replacement therapy where overrated.
The Dangers of HRT
Prior to the WHI study, medical practitioners were aware that HRT increased the incidence of breast cancer. The WHI study confirmed this. However, generally, medical opinion is that HRT does not cause the initiation of breast cancer but promotes its growth. Because it promotes its growth, it appears, in a given study period that more breast cancers are occurring. This is only because the hormones promote breast cancer growth and therefore make them detectable within the study period. The flip side of this coin is that if a breast cancer is discovered in a woman using HRT is usually discovered at a lower stage in grade and there is a 16% improved survival rate. Even if BHRT promotes the growth of breast cancer in a similar fashion I do not believe that this is a significant issue to its use. Some proponents of BHRT believed that estriol instead of estradiol and natural progesterone instead of progestins may cause less promotion of breast cancer growth.
The WHI study demonstrated an increase in cardiovascular events including myocardial infarction (heart attacks), strokes, and deep vein thrombophlebitis (leg clots). The study group was on average 12 years into menopause and 63 years old. It is understandable that this group may have established atherosclerosis (hardening of the arteries). It has been well demonstrated in many studies prior to the WHI that HRT slows down the progression of atherosclerosis. It is my clinical opinion, as well as many other physicians, that these cardiovascular events are likely not increased in younger women who are usually seen clinically for symptoms of menopause around the age of 48 to 52 years old. BHRT may affect cardiovascular events less because of estriol and natural progesterone and its transdermal (through the skin) application. However, this has not been proven.
Conventional HRT significantly decreased osteoporosis. This decrease in osteoporosis has not been demonstrated with BHRT but in my opinion is likely to occur. I have followed bone density in several patient and observed consistent improvement.
Our professional organizations consider the use of conventional HRT in symptomatic women safe for five years. After five years, the general consensus is that the pros and cons of continuing HRT should be considered by a woman and her doctor and a decision to continue or discontinue hormones should be made by the women on advice of her doctor. I have no reason to believe that this should be different with BHRT. It is good practice to taper the use of conventional HRT gradually to avoid recurrence of menopausal symptoms. If after 5 years a woman chooses to discontinue BHRT, this principle should be no different.
My Clinical Experience so far?
As I stated in an earlier section of this information sheet, I wrote my first prescription for bioidentical hormone replacement therapy in 2003. At the annual meeting of the Canadian Fertility and Andrology Society in 2008, I presented two studies on BHRT. The clinical approach I have developed in prescribing BHRT is to take a complete history and possibly a directed physical examination on the initial consultation visit. If I am unsure if the patient’s symptoms are due to menopause, I will do a hormone profile before proceeding. However, if I believe the
| Initial Observations on Bioildentical Hormone Replacement using Compounded Biest and Progesterone Cream
James S.B. Martin*. Southern Ontario Fertility Technologies, London, Ontario, Canada
Objective: To document the efficacy and side effects of Bioildentical Hormone Replacement Therapy in symptomatic post-menopausal women using Biest 0.625 (20% estradiol and 80% estriol) and 3% progesterone cream.
Methods: Case series of 78 consecutive post-menopausal (FSH above 40) seen in consultation for menopausal symptoms and interested in Bioidentical Hormone Replacement Therapy was studied. Initial symptoms were documented; a hormone profile done and Biest 0.625 per milliliter and 3% Progesterone cream prescribed using a single compounding pharmacist who purchases the cream and hormones from the Professional Compounding Centre of America (PCCA)
Results: 74 of 79 women (95%) experienced a significant (greater than 50%) decrease in hot flashes. Average reduction in hot flashes was 84%. 61 of 76 (80%) women had reduced night sweats. Other reported improvements were 36 (46%) had decreased insomnia, 31 (39%) had improved vaginal dryness, 22 (28%) 1 improvement in short term memory, 11 (14%) claimed improved depression, 9 (11%) claimed decreased anxiety. Reported side effects were 3 (4%) breast tenderness and 2 (3%) with nausea.
Conclusions: Compounded Bioidentical hormone replacement therapy in the form of Biest 0.625 per milliliter and 3% Progesterone cream appears to be very effective and very well tolerated. |
symptoms are compatible with menopause, I will do a hormone profile and prescribe Biest and progesterone cream. I will ask the patient to repeat a hormone profile and see me in about six weeks. At that time I will assess the response to therapy using mostly their symptoms but also referring to the two hormone profiles. At this time, I may add more Biest or progesterone cream or add testosterone cream depending on my assessment of the symptoms guided with the two hormone profiles. Usually it takes a few visits to adjust the BHRT to have the desired beneficial affects.
| 3% Testosterone Cream for decreased libido in Post Menopausal Women
James S.B. Martin*. Southern Ontario Fertility Technologies, London, Ontario, Canada
Objective: To document the efficacy and side effects of compounded 3% testosterone cream in post-menopausal women to improve decreased libido
Methods: 78 women seen in consultation were diagnosed as post-menopausal and were interested in Bioidentical Hormone Replacement Therapy. All were administered a questionnaire concerning their symptoms. 43 of the 78 listed decreased libido as a concerning symptom. All were originally treated with Biest 0.625 cream and 3% progesterone cream and were seen in follow-up 4 to 5 weeks later. 35 women were then started on 3% testosterone cream (0.25 to 0.5 ml per day). Efficacy and side effects were questioned using a predetermined series of questions and recorded.
Results: Of the original 43 women complaining of decreased libido, 35 were placed on testosterone cream (4 improved with the original treatment and 4 declined). 31 of 35 (89%) experienced improved libido in general. 30 claimed increased interest, 32 claimed increased arousal and 31 claimed increased ability to reach climax. Of the 31 who experienced increased ability to reach climax, 14 had lost the ability completely prior to treatment. 34 of 35 women claimed increased frequency of intercourse or attempted intercourse. Treatment was followed for 6 to 18 months and 34 of 35 women chose to continue treatment.
22 of 35 claimed increased hair growth, 19 of 35 increased acne, 11 voice change, 15 increased energy levels and 16 an increased feeling of well-being. 9 of 35 had partners that experienced sexual difficulties (3 with premature ejaculation and 6 with difficulty maintaining an erection or ejaculation.
Conclusions: Compounded 3% testosterone cream is very effective for improvement of decreased libido in post-menopausal women experiencing decreased libido. It has side effects which are documented but none of which appear to be severe enough for voluntary discontinuation of treatment. |
The first study I reported my initial observations from prescribing the Biest and progesterone cream. I have included an abstract on this page (just above). The abstract demonstrates without a doubt that this treatment is beneficial for relief of hot flashes. 74 of 79 (95%) of women responded with a significant decrease in their hot flashes. The treatment was also beneficial for many of the other symptoms they reported (see the abstract). Very few side effects were reported and most of these were transient.
The second study documented the addition of testosterone cream in some women who continue to complain of decreased libido after the initial use of Biest and progesterone cream. As you can see from this second study (included on the last page), some women had return of their libido without the use of testosterone but of those who did not, most of them responded to testosterone. Testosterone cream did have side effects and these were all documented but none of them were severe. In fact, only one of the 35 women initially started on testosterone cream discontinued it.
The Future
In the future, we are planning additional studies on BHRT and hope to complete a randomized controlled trial comparing its use to placebo to prove its effectiveness. Such a clinical trial will be very difficult. No external funding is available. Also, BHRT products such as Biest, progesterone and testosterone cream are not Health Canada approved. Therefore, before we get ethical approval for this clinical trial we will need to get permission from Health Canada to use these nonapproved drugs in the clinical trial.
Also, we will continue and expand our clinical use of BHRT. When I used to prescribe pharmaceutical HRT it was very rewarding as a physician because women were grateful for relief of their menopausal symptoms. My impression after five years of prescribing BHRT is that women not only get relief of most of their menopausal symptoms but it is not uncommon for them to state that they feel as well as they did 10 or 20 years ago.
If you are Interested…
At the present time, very few referrals for BHRT are initiated by physicians. As knowledge of BRT increases I am sure physician referrals will become much more common. If you are interested in learning about BHRT, there are many resources available both on the Internet and books. However, remember that I stated earlier in this information sheet that much controversy exists even between BHRT practitioners. Consultations for BHRT are available at S.O.F.T. on referral from your family doctor or gynecologist. Remember that your family doctor is your best healthcare resource and will often have a very open mind regarding this kind of treatment. Patients will also be accepted on referral from a compounding pharmacist or naturopath.
James Martin MD ©
S.O.F.T., 555 Southdale Rd E, Suite 107
London, Ontario, N6E1A2
Tel: (519) 685-5559
web page: www.soft-infertility.com
Women’s and Men’s Health Series
London Laser Health Care Centre
Debra Taylor
519-641-3100
debra@londonlaser.ca
At London Laser Health Care Centre we believe that well-being comes from within. Body, mind, heart and soul are one. You can empower yourself by learning to listen to your inner wisdom through your body. We also believe transforming healthcare begins with education. Our goal is to bring you the information in a fun and interactive program so you have the tools you need to make an informed decision. We are now registering for our winter series.
The 3 hour workshops will take place Wednesday evenings in February at The Medicine Shoppe Pharmacy, 312 Commissioners Rd. W. London, from 7 pm to 10 pm.
Francis Mokenela, compounding pharmacist will be on hand each week to answer questions about saliva testing and bio-identical hormones.
Each workshop is $20 and seating is limited. Call 519-641-3100 or email debra@londonlaser.ca to reserve your seat.
Feb 3 Let’s Talk Hormones
- What are hormones?
- The results of the Women’s Health Initiative
- What are bio-identical hormones?
Feb 10 Menopause and Andropause – Having the Time of Your Life
- The ‘Biological Breakdown’ of what’s occurring inside the body;
- Common treatments to combat the symptoms commonly associated with menopause and andropause
- The ‘Natural’ answer to our prayers.
- Estrogen, progesterone and testosterone
Feb 17 It’s My Metabolism! – Stoking Your Internal Fire
- How to build an optimal metabolic fire and keep it burning
- Specific ways that you can improve your furnace, fire, and fuel
- Great energy, vitality, clarity, ideal weight, and stable mood are all outcomes of a clean burning fire that’s getting clean fuel
- Thyroid and adrenal fatigue
Feb 24 Is Stress the Root of All Health Problems
- What is stress?
- What happens inside our bodies when we are stressed (The stress response).
- What do stress hormones do?
- The effect of excess stress hormones.
- Cortisol and Osteoporosis
She She
Are you passionate about purses? A jewellery junkie or do you get super excited about scarfs? Whether you’re a seasoned fashionista or an admirer of all things accessory, a SheShe party is just for you!
SheShe parties are the best reason we can think of to call your girls over for some really fun girl time! It’s pretty easy, too… You invite your “people” and we’ll bring hundreds of the newest fashion accessories. We carry everything from purses and wallets to jewellery, scarfs, hats and sunglasses. We really do have something for everyone – AND all our products are incredibly affordable with nothing over 60$!
Come and join us at the Women’s Lifestyle Show March 6-7th at the London Convention Centre. We’ll have a great selection of all the hottest spring styles at our awesome prices! Check us out and book your very own SheShe party and discover the incredible incentives. Can you say FREE PURSE JUST for hosting?!?
www.sheshe.ca
Julie Khan – julie@sheshe.ca
Amanda Reynaert – amanda@sheshe.ca
Other Guests:
Southern Ontario Fertility Technologies
555 Southdale Rd, Suite 107
London, ON, N6E 1A2 Phone: (519) 685-5559
Fax: (519) 685-5519
E-mail: info@soft-infertility.com
www.soft-infertiity.com
She She
www.sheshe.ca
Julie Khan – julie@sheshe.ca
Amanda Reynaert – amanda@sheshe.ca
London Laser Health Care Centre
Debra Taylor
519-641-3100
debra@londonlaser.ca
Tom McNulty
Author- Clean Like A Man
Email: tmcnulty22@comcast.net
cleanlikeaman.com
Marty Menard
Elite Personal Training Studio
73 York St.
London, Ontario
(519) 645-2578
marty@elitepersonaltraining.ca
www.elitepersonaltraining.ca/
Katina Kritikos
Ethos the Spa
www.ethosthespa.com
633 Richmond Street
1-800-ETHOSPA
London and area (519)438-7327
Dr. Jamie and Joel Richards
Café of Life Chiropractic
www.cafeoflifelondon.com
E-mail: jamie@cafeoflifelondon.com
joel@faceoflifelondon.com
394 Oxford St. East
(519)439-5353
Jeff Robb
Turner Drug Store Ltd.
www.turnerdrugs.com
E-mail: turner@turnerdrugs.com
52 Grand Avenue at Carfrae Crescent,
Tel: 1 (800) 566-8482
Hollywood Tan London
1021 Wonderland Road South
London, Ontario
N6K 3V1
519.649.0385
1.877.TAN4FUN (8264386)
EMAIL:
info@hollywoodtanlondon.com
www.hollywoodtanlondon.com
Next Week on the show we will be talking about the health benefits of tea with a company called’ Steeped and Infused’. Did you know tea reduces fatigue and contains vitamins, minerals and amino acids plus builds a strong health heart? Find our more next Saturday. Our enviro expert Paul Vanderwerf is back to talk about calculating the green house gas generations in our home and tips to reduce it. In addition, Technology Journalist Carmi Levy will be talking about something that I’m sure we can all relate to- parental control vs. privacy concerns when it comes to the internet and your kids.
